All Comments by Elliott Mufson

  1. Cognitive enhancement therapy for Alzheimer's disease. The way forward.
  2. Alzheimer's disease in twins.
  3. No association between apolipoprotein E epsilon 4 allele and rate of decline in Alzheimer's disease.
  4. Mechanism of Alzheimer neurofibrillary degeneration and the formation of tangles.
  5. A cellular mechanism for the neuronal changes underlying Alzheimer's disease.
  6. Interaction between Alzheimer's disease beta A4 precursor protein (APP) and the extracellular matrix: evidence for the participation of heparan sulfate proteoglycans.
  7. Vascular variant of Alzheimer's disease characterized by severe plaque-like beta protein angiopathy.
  8. Automated identification and quantitative morphometry of the senile plaques of Alzheimer's disease.
  9. Aging and Alzheimer's disease: lessons from the Nun Study.
  10. Endoproteolytic cleavage and proteasomal degradation of presenilin 2 in transfected cells.
  11. Induction of a specific tau Alzheimer epitope in SY-5Y neuroblastoma cells.
  12. Acetylcholine, aging, and Alzheimer's disease.
  13. Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain.
  14. Insulin-like growth factor I protects and rescues hippocampal neurons against beta-amyloid- and human amylin-induced toxicity.
  15. The mean A beta load in the hippocampus correlates with duration and severity of dementia in subgroups of Alzheimer disease.